"Neutropenia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A decrease in the number of NEUTROPHILS found in the blood.
| Descriptor ID |
D009503
|
| MeSH Number(s) |
C15.378.553.546.184.564
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Neutropenia".
Below are MeSH descriptors whose meaning is more specific than "Neutropenia".
This graph shows the total number of publications written about "Neutropenia" by people in this website by year, and whether "Neutropenia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 0 | 1 | 1 |
| 1996 | 0 | 2 | 2 |
| 2000 | 2 | 1 | 3 |
| 2001 | 2 | 0 | 2 |
| 2002 | 2 | 1 | 3 |
| 2003 | 0 | 3 | 3 |
| 2004 | 0 | 2 | 2 |
| 2005 | 3 | 0 | 3 |
| 2006 | 2 | 3 | 5 |
| 2007 | 4 | 0 | 4 |
| 2009 | 1 | 1 | 2 |
| 2010 | 1 | 2 | 3 |
| 2011 | 1 | 0 | 1 |
| 2012 | 2 | 1 | 3 |
| 2013 | 3 | 1 | 4 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2019 | 2 | 1 | 3 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neutropenia" by people in Profiles.
-
Hakim H, Billett AL, Xu J, Tang L, Richardson T, Winkle C, Werner EJ, Hord JD, Bundy DG, Gaur AH. Mucosal barrier injury-associated bloodstream infections in pediatric oncology patients. Pediatr Blood Cancer. 2020 08; 67(8):e28234.
-
Farra C, Raimondi S, Abboud M. Acquired centromeric heteromorphism of chromosome 7 yields discordant results between fluorescent in situ hybridization and karyotype analysis in a child with severe congenital neutropenia. Pediatr Hematol Oncol. 2019 Oct; 36(7):432-437.
-
Chen B, Nagai S, Armitage JO, Witherspoon B, Nabhan C, Godwin AC, Yang YT, Kommalapati A, Tella SH, DeAngelis C, Raisch DW, Sartor O, Hrushesky WJ, Ray PS, Yarnold PR, Love BL, Norris LB, Knopf K, Bobolts L, Riente J, Luminari S, Kane RC, Hoque S, Bennett CL. Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada. Oncologist. 2019 04; 24(4):537-548.
-
Milic M, Hall M, Hawkins A, Gogbashian A, Rustin G, Sharma A. A Qualitative Analysis of the Impact of Carboplatin AUC 10 on Physical, Work Functioning and Bone Marrow Toxicity Among Seminoma Patients - A Single-centre Experience. In Vivo. 2019 Jan-Feb; 33(1):233-237.
-
Gaur AH, Bundy DG, Werner EJ, Hord JD, Miller MR, Tang L, Lawlor JP, Billett AL. A Prospective, Holistic, Multicenter Approach to Tracking and Understanding Bloodstream Infections in Pediatric Hematology-Oncology Patients. Infect Control Hosp Epidemiol. 2017 06; 38(6):690-696.
-
Costa LJ, Fanning SR, Stephenson J, Afrin LB, Kistner-Griffin E, Bentz TA, Stuart RK. Sequential ofatumumab and lenalidomide for the treatment of relapsed and refractory chronic lymphocytic leukemia and small lymphocytic lymphoma. Leuk Lymphoma. 2015 Mar; 56(3):645-9.
-
Chaudhary UB, Verma N, Keane T, Gudena V. A phase II study of gemcitabine and irinotecan in patients with locally advanced or metastatic bladder cancer. Am J Clin Oncol. 2014 Apr; 37(2):188-93.
-
Strassels SA, Dickson M, Norris LB, Bennett CL. Primary prophylaxis with hematopoietic colony stimulating factor: insights from a Canadian cost-effectiveness analysis. J Natl Cancer Inst. 2013 Aug 07; 105(15):1072-3.
-
Djulbegovic B, Norris LB, Bennett CL. Colony-stimulating factors for febrile neutropenia. N Engl J Med. 2013 07 18; 369(3):286.
-
Bennett CL, Djulbegovic B, Norris LB, Armitage JO. Colony-stimulating factors for febrile neutropenia during cancer therapy. N Engl J Med. 2013 Mar 21; 368(12):1131-9.